Geroprotectors are agents that slow biological aging and delay development of age-related diseases by targeting core aging mechanisms. These compounds enhance cellular maintenance, reduce damage accumulation, and improve stress resilience. Geroprotectors act across multiple tissues and pathways, offering broad protective effects rather than disease-specific treatment. Their evaluation focuses on healthspan improvement, functional preservation, and biological age modulation. Geroprotectors represent a promising class of interventions that translate aging biology into preventive medicine. Understanding geroprotectors supports systematic approaches to identifying compounds that promote healthy aging at the molecular and systemic levels.
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom